Literature DB >> 32433010

SARS-CoV-2: The Path of Prevention and Control.

Amal A Mohamed1, Nouran Mohamed2, Seham Mohamoud3, Fawkia E Zahran4, Rania Abdelmonem Khattab5, Dalia Ali El-Damasy6, Eman Alsayed7, Sherief Abd-Elsalam8.   

Abstract

The 2019 coronavirus pandemic (COVID-19) continues to expand worldwide. Although the number of cases and the death rate among children and adolescents are reported to be low compared to adults, limited data have been reported. We urgently need to find the treatment and vaccine to stop the epidemic. Vaccine development is in progress, but any approved and effective vaccine for COVID-19 will take at least 12 to 18 months. The World Health Organization (WHO), the Center for Disease Control and Prevention (CDC), and the Food and Agriculture Organization (FAO) have issued instructions and strategies for controlling COVID-19 outbreak to the general public, physicians, travelers and injured patients to follow so that the transmission to a healthy population can be prevented. In this review, we summarize demographic data, clinical characteristics, complications and outcomes and finally prevention and control strategies for this serious pandemic. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Coronavirus; SARS; epidemic; pandemic; vaccine; viruses

Mesh:

Year:  2021        PMID: 32433010     DOI: 10.2174/1871526520666200520112848

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  6 in total

1.  Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome.

Authors:  Rana Kadry; Andrea Sikora Newsome; Payaningal R Somanath
Journal:  Infect Disord Drug Targets       Date:  2021

2.  Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial.

Authors:  Sherief Abd-Elsalam; Shaimaa Soliman; Eslam Saber Esmail; Mai Khalaf; Ehab F Mostafa; Mohammed A Medhat; Ossama Ashraf Ahmed; Mohamed Samir Abd El Ghafar; Mohamed Alboraie; Sahar M Hassany
Journal:  Biol Trace Elem Res       Date:  2020-11-27       Impact factor: 3.738

3.  Epidemiological Characteristics of Infectious Diseases Among Travelers Between China and Foreign Countries Before and During the Early Stage of the COVID-19 Pandemic.

Authors:  Zheng Luo; Wei Wang; Yibo Ding; Jiaxin Xie; Jinhua Lu; Wen Xue; Yichen Chen; Ruiping Wang; Xiaopan Li; Lile Wu
Journal:  Front Public Health       Date:  2021-11-03

4.  Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study.

Authors:  Sherief Abd-Elsalam; Rasha A Noor; Rehab Badawi; Mai Khalaf; Eslam S Esmail; Shaimaa Soliman; Mohamed S Abd El Ghafar; Mohamed Elbahnasawy; Ehab F Moustafa; Sahar M Hassany; Mohammed A Medhat; Haidi Karam-Allah Ramadan; Maii A S Eldeen; Mohamed Alboraie; Ahmed Cordie; Gamal Esmat
Journal:  J Med Virol       Date:  2021-06-07       Impact factor: 20.693

5.  Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence.

Authors:  Md Arif Billah; Md Mamun Miah; Md Nuruzzaman Khan
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.240

6.  Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.

Authors:  Sherief Abd-Elsalam; Eslam Saber Esmail; Mai Khalaf; Ehab Fawzy Abdo; Mohammed A Medhat; Mohamed Samir Abd El Ghafar; Ossama Ashraf Ahmed; Shaimaa Soliman; Ghada N Serangawy; Mohamed Alboraie
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.